Gefen Capital

Gefen Capital is a US-Israeli venture capital firm established in 2016, focusing on high-potential Israeli startups with disruptive technologies. The firm leverages its strong US network and operational experience to assist startups in penetrating the US market. Unlike many VCs, Gefen Capital offers a flexible investment strategy with no deadlines for exits, aiming to create value through strategic support and capital investment.

The firm targets early-stage companies, including Seed, Series A, Series B, and Growth Stage, with investments ranging from $1 million to $3 million. Its portfolio spans various sectors, including Technology, Healthcare, Consumer, FinTech, and Ag-Tech. Notable portfolio companies include EarlySense, Capitalise, Rapid Medical, Douxmatok, and Saturas.

Gefen Capital's principals possess extensive operational experience in building and managing companies, complemented by capital market expertise. This combination enables the firm to provide strategic guidance and patient capital, assisting entrepreneurs in navigating growth challenges and achieving optimal exit strategies. The firm's strong US network, with investors collectively representing over $20 billion in net worth, offers invaluable support to Israeli startups seeking to scale in the US market.